BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Treatment
23 results:

  • 1. A cross-sectional survey examining clinician characteristics, practices, and attitudes associated with adoption of the 2019 American Society for Colposcopy and Cervical Pathology risk-based management consensus guidelines.
    Vadaparampil ST; Fuzzell LN; Brownstein NC; Fontenot HB; Lake P; Michel A; McIntyre M; Whitmer A; Perkins RB
    Cancer; 2023 Sep; 129(17):2671-2684. PubMed ID: 37221653
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigating the Underutilization of uterine Fibroid Embolization by Surveying Practice Preferences of Obstetricians/Gynecologists.
    Kubiszewski K; Maag B; Hunsaker P; Iwai T; Lim J; Duffey E; Varlamov A; Yoo R
    J Vasc Interv Radiol; 2023 Aug; 34(8):1430-1434. PubMed ID: 37127177
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Perceptions of Cervical cancer Screening in Rural Guatemala.
    Bassette E; Mabachi N; Kennedy M; Mendez-Puac F
    Hisp Health Care Int; 2022 Jun; 20(2):156-163. PubMed ID: 34467792
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A new development in ultrasound-compatible gynecologic brachytherapy simulators.
    Fields EC; Joyner MM; Singer L; Todor D
    Brachytherapy; 2020; 19(6):783-786. PubMed ID: 33168476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibitory and protective effect of obovatol against uterine fibroid (leiomyoma) cells.
    Chen L; Hou Q; Feng L; Xin LL; Ma L
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):281-285. PubMed ID: 32122859
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Lymphovascular Space Invasion for Endometrial cancer: Undertreatment and Overtreatment Risks: A Survey of the Spanish Gynecologic Oncology Group.
    Gorostidi Pulgar M; Diaz de la Noval B; Gil-Ibañez B; Lago Leal V; Jaunarena Marin I; Padilla Iserte P
    Int J Gynecol Cancer; 2017 Jul; 27(6):1191-1199. PubMed ID: 28557833
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
    Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [LAPAROSCOPIC treatment OF INTRALIGAMENTAL LEIOMYOMA PER MAGNA].
    Bechev B; Magunska N; Kovachev E; Ivanov S
    Akush Ginekol (Sofiia); 2016; 55(1):66-8. PubMed ID: 27514135
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hysteroscopic Patterns in Women on treatment With Ulipristal Acetate 5 mg/day: A Preliminary Study.
    Bettocchi S; Baranowski WE; Doniec J; Ceci O; Resta L; Fascilla FD; Mitola PC; Tinelli R; Cicinelli E
    J Minim Invasive Gynecol; 2016; 23(5):664-9. PubMed ID: 26803918
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy.
    Barron KI; Richard T; Robinson PS; Lamvu G
    Obstet Gynecol; 2015 Dec; 126(6):1174-1180. PubMed ID: 26595561
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Are the University Hospitals in Puerto Rico following Current Guidelines for Cervical cancer Screening?
    Méndez K; Rodríguez N; Sánchez I; Lozada Y; Piñero I; Donate D; Romaguera J
    P R Health Sci J; 2015 Sep; 34(3):142-7. PubMed ID: 26356738
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Leptin promotes human endometrial carcinoma cell proliferation by enhancing aromatase (P450arom) expression and estradiol formation.
    Liu L; Wang L; Zheng J; Tang G
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):198-201. PubMed ID: 23932299
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.
    Wu X; Yan Q; Zhang Z; Du G; Wan X
    Oncol Rep; 2012 May; 27(5):1488-96. PubMed ID: 22327423
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
    Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
    J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Upregulation of leptin-receptor in placental cells by hypoxia.
    Klaffenbach D; Meissner U; Raake M; Fahlbusch F; Alejandre Alcazar MA; Allabauer I; Kratzsch J; Rascher W; Dötsch J
    Regul Pept; 2011 Feb; 167(1):156-62. PubMed ID: 21237211
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
    Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
    Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [The role of ERK1/2 in leptin promoting the proliferation of human endometrial cancer cell line Ishikawa].
    Gong C; Liu Y; Xiao W; Yin J; Wang DH; Sheng H
    Ai Zheng; 2007 Nov; 26(11):1211-4. PubMed ID: 17991320
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.
    Koda M; Sulkowska M; Wincewicz A; Kanczuga-Koda L; Musiatowicz B; Szymanska M; Sulkowski S
    Ann N Y Acad Sci; 2007 Jan; 1095():90-8. PubMed ID: 17404022
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mexican physicians' knowledge and attitudes about the human papillomavirus and cervical cancer: a national survey.
    Aldrich T; Becker D; García SG; Lara D
    Sex Transm Infect; 2005 Apr; 81(2):135-41. PubMed ID: 15800091
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Point dose variations with time during traditional brachytherapy for cervical carcinoma.
    King GC; Bloomer WD; Kalnicki S; Faul CM; Gooding WE; Stockstill TF; Wu A; Buchsbaum R; Chen AS; Gerszten K; Kalend A
    Med Dosim; 2000; 25(2):77-80. PubMed ID: 10856685
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.